Developer docs
API playgroundTry for free, no card

Search company profiles

Highline Sciences

Full company profile

uuid000l4o7

Namestring
Highline Sciences
Legal namestring
Highline Consulting LLC
Company typeenum
Private
Founded yearint
2014
Descriptiontext

Highline Sciences (legal entity Highline Consulting LLC) is a specialized, oncology-focused contract research organization and consultancy founded in 2014 and headquartered in San Francisco. The firm provides full-service and functional clinical trial support to small and mid-market biotechnology companies, spanning Phase I through Phase III studies, with particular depth in orphan designation, first-in-human, biomarker/companion diagnostic, dose escalation/expansion, and modern adaptive trial designs (basket, umbrella). Service modules cover project management, feasibility and site identification, study startup, clinical monitoring and site management, regulatory affairs, data management, biostatistics, medical affairs, safety and pharmacovigilance, medical writing, quality assurance, investigator payments, clinical development consulting, and staff augmentation. Revenue is generated through professional-services arrangements — bespoke, partnership-oriented engagements priced per project rather than on standardized SaaS terms — with no publicly disclosed pricing.

The operational technology stack is built on third-party best-in-class platforms rather than proprietary software: Veeva Vault CTMS/eTMF for study management, Oracle Argus Safety for adverse event management (configured in-house for sponsor-specific deployments), and Medidata RAVE and Medrio as preferred EDC systems. Distribution is direct B2B field sales to biotech sponsors, with services delivered globally despite a single San Francisco headquarters. The company was acquired by Tempus and has been rebranded as Tempus Compass, integrating oncology CRO delivery into Tempus's broader portfolio of sequencing, data collaborations, and AI-enabled clinical trial solutions.

Short descriptiontext

Highline Sciences is an oncology-focused contract research organization serving small to mid-market biotech companies with full-service and functional clinical trial support from Phase I through Phase III. The firm was acquired by Tempus and rebranded as Tempus Compass.

Operating statusenum
Acquired
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSan Francisco, United States
HQ citystring
San Francisco
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
oncology clinical trials, contract research organization, clinical trial management, drug development consulting, biotech clinical services
Industry5 codes
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGACAC
Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts)
SECONDARYBPACADAL
Life Sciences & Biotech (R&D/Clinical) Staffing
Business & Public Services/HR, Staffing & Recruitment Services/Professional & Technical Staffing (IT/Engineering/Healthcare/Finance)
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs
NAICS code3 codes
  • Research and Development in the Physical, Engineering, and Life Sciences54171
  • Scientific Research and Development Services5417
  • Other Scientific and Technical Consulting Services54169
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Clinical Research Organization (CRO) Services
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Full-Service Clinical Trial Support
TypeProfessional Services
Description

Comprehensive CRO services including project management, clinical monitoring, data management, biostatistics, regulatory affairs, and medical writing for Phase I-III oncology trials

highlinesciences.com
2Functional Service Support
TypeProfessional Services
Description

Individual resource augmentation and specialized services such as site management, feasibility, study startup, investigator payments, and quality assurance

highlinesciences.com
3Clinical Development Consulting
TypeProfessional Services
Description

Consulting services for early-stage companies preparing for clinical development and established companies needing program support

highlinesciences.com
4Staff Augmentation
TypeProfessional Services
Description

Providing qualified clinical staff at all levels to augment client workforces, including evaluation of existing staff and identification of specialists

highlinesciences.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Operations, Technology or R&D, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 record
1Tempus Compass
Description

The rebranded clinical trial solutions division of Highline Sciences under Tempus, offering clinical trial services to biopharma companies.

highlinesciences.com
Core offering1 text field

Highline Sciences is a specialized, full-service Contract Research Organization (CRO) and consultancy that provides oncology-focused clinical trial support for small to mid-market biotech companies. Services span Phase I through Phase III trials and include project management, clinical monitoring, data management, biostatistics, regulatory affairs, safety/pharmacovigilance, medical writing, and quality assurance, delivered as full-service, functional, or staff augmentation engagements.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Highline Sciences is a specialized, full-service CRO and consultancy founded from within an oncology biotech. It offers a comprehensive suite of clinical trial services structured as integrated modules including project management, feasibility and site identification, study startup, clinical monitoring and site management, regulatory services, data management, biostatistics, medical affairs, safety and pharmacovigilance, medical writing, and quality assurance. The company also provides staff augmentation, clinical development consulting, and specialized oncology trial design services (Phases I-III, orphan designation, first-in-human, modern basket/umbrella designs, biomarker and companion diagnostics, dose escalation). Services are delivered using operational technology platforms including Veeva Vault CTMS/eTMF, Oracle Argus Safety, and EDC systems (Medidata RAVE, Medrio). Highline Sciences was acquired by Tempus and has been rebranded as Tempus Compass, integrating into Tempus's broader data and AI-powered healthcare solutions.

Product and service3 records
1Clinical Trial Services
CategoryCRO Services
Description

Full-service and functional clinical trial support for small to mid-market biotech companies, spanning Phase I through Phase III, with deep expertise in oncology. Delivered as a coordinated engagement with A-team support globally.

2Clinical Development Consulting
CategoryConsulting Services
Description

Consulting services for early-stage biotech companies preparing for clinical development and for established companies needing extra program support, including trial planning, forecasting, and execution.

3Staff Augmentation
CategoryStaffing Services
Description

Workforce augmentation service that evaluates existing client staff, identifies required additional skills, and supplies qualified clinical professionals and industry specialists at all levels to complement sponsor workforces.

Partnership4 partners
Strategic tierCoreTypeTechnology or Integration
Description

Highline Sciences utilizes Veeva Vault CTMS (Clinical Trial Management System) and eTMF (electronic Trial Master File) systems for integrated study management. The integration enables streamlined processes from site activation through close-out within a single system, increasing visibility, quality, and efficiency throughout the study lifecycle.

Strategic tierCoreTypeTechnology or Integration
Description

Highline Sciences uses Oracle Argus Safety, the industry-leading adverse event management system. The Argus Safety database can be configured for single or multiple studies and compounds within a sponsor-specific Argus Enterprise, with all configuration completed in-house for flexibility and responsiveness.

Strategic tierCoreTypeTechnology or Integration
Description

Medidata RAVE is a preferred EDC system due to its flexibility in design and ease of use for site staff. Data is readily visible and available for reporting, improving ability to analyze and make key decisions throughout clinical trials.

4Tempus
Strategic tierFlagshipTypeStrategic or Co-development Partner
Description

Highline Sciences has been acquired by Tempus and operates under the Tempus Compass brand. Tempus brings the power of data and AI to healthcare and offers multiple solutions for biopharma ranging from sequencing and data collaborations to clinical trial solutions. This acquisition integrates Highline's CRO services with Tempus's broader data and AI capabilities.

highlinesciences.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
1Tempus AI
TypeBroad incumbent
Description

Parent company of Highline Sciences (now Tempus Compass). Tempus is a data and AI healthcare company that acquired Highline to offer clinical trial solutions alongside its sequencing and data collaboration services. Relevant as the integrated platform that Highline now operates within.

TypeDirect peer
Description

Mid-sized full-service CRO with particular strength in oncology, cardiovascular, and metabolic therapeutic areas. Medpace serves small and mid-market biotech sponsors with a full-service model, directly competing with Highline/Tempus Compass in oncology Phase I-III trials.

TypeBroad incumbent
Description

Global tier-1 CRO offering full-service clinical trial support across all therapeutic areas including oncology. Competitor to Highline for mid-market and large biopharma oncology trials, with broader scale, site networks, and technology platform.

TypeBroad incumbent
Description

Global CRO providing full-service and functional clinical trial services across therapeutic areas including oncology. Competes with Highline/Tempus Compass for biotech-sponsored oncology trials, particularly at the larger end of the market.

TypeBroad incumbent
Description

Large global CRO offering comprehensive oncology clinical development services. A direct competitor in the mid-market oncology CRO space where Highline/Tempus Compass operates, with stronger late-phase capabilities.

TypeDirect peer
Description

Mid-sized CRO with strong oncology and early-phase specialization serving small and mid-market biopharma. Comparable to Highline in its boutique positioning and therapeutic-area focus, making it a direct peer for oncology biotech clients.

TypeBroad incumbent
Description

Global full-service CRO spun out from LabCorp, offering clinical development services across therapeutic areas including oncology. Competes broadly with Highline for oncology trial work at scale.

TypeBroad incumbent
Description

Global CRO with full-service and functional service offerings across therapeutic areas including oncology. Competes with Highline/Tempus Compass for mid-market and enterprise biotech sponsors.

TypeEmerging player
Description

Specialized clinical development services provider with oncology focus and complementary biomarker/precision medicine capabilities. Overlaps with Highline's oncology specialty positioning and biomarker-driven trial design expertise.

TypeDirect peer
Description

Oncology-focused CRO unit within IQVIA historically serving small/mid-market oncology biotechs. Direct historical competitor to Highline Sciences in specialized oncology trial services for emerging biotech sponsors.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

Integration4 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Highline Sciences

Clinical Research Organization (CRO) Serviceshighlinesciences.com

Highline Sciences is an oncology-focused contract research organization serving small to mid-market biotech companies with full-service and functional clinical trial support from Phase I through Phase III. The firm was acquired by Tempus and rebranded as Tempus Compass.

What Highline Sciences does

Highline Sciences (legal entity Highline Consulting LLC) is a specialized, oncology-focused contract research organization and consultancy founded in 2014 and headquartered in San Francisco. The firm provides full-service and functional clinical trial support to small and mid-market biotechnology companies, spanning Phase I through Phase III studies, with particular depth in orphan designation, first-in-human, biomarker/companion diagnostic, dose escalation/expansion, and modern adaptive trial designs (basket, umbrella). Service modules cover project management, feasibility and site identification, study startup, clinical monitoring and site management, regulatory affairs, data management, biostatistics, medical affairs, safety and pharmacovigilance, medical writing, quality assurance, investigator payments, clinical development consulting, and staff augmentation. Revenue is generated through professional-services arrangements — bespoke, partnership-oriented engagements priced per project rather than on standardized SaaS terms — with no publicly disclosed pricing.

The operational technology stack is built on third-party best-in-class platforms rather than proprietary software: Veeva Vault CTMS/eTMF for study management, Oracle Argus Safety for adverse event management (configured in-house for sponsor-specific deployments), and Medidata RAVE and Medrio as preferred EDC systems. Distribution is direct B2B field sales to biotech sponsors, with services delivered globally despite a single San Francisco headquarters. The company was acquired by Tempus and has been rebranded as Tempus Compass, integrating oncology CRO delivery into Tempus's broader portfolio of sequencing, data collaborations, and AI-enabled clinical trial solutions.

Highline Sciences firmographics

Firmographics
Name
Highline Sciences
Legal name
Highline Consulting LLC
Website
https://highlinesciences.com
Company type
Private
Founded year
2014
Operating status
Acquired
Headcount range
1–10 employees
Short description
Highline Sciences is an oncology-focused contract research organization serving small to mid-market biotech companies with full-service and functional clinical trial support from Phase I through Phase III. The firm was acquired by Tempus and rebranded as Tempus Compass.
Ownership category
akta.pro rank

Highline Sciences industry classification

Industry
Product category
Clinical Research Organization (CRO) Services
NAICS
Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (54169)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAAAA
Clinical CROs (Phase I–IV)
SECONDARYHLAGAAAL
Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)
SECONDARYHLAGACAC
Clinical Site Start-Up & Activation (Regulatory/Ethics/Contracts)
SECONDARYBPACADAL
Life Sciences & Biotech (R&D/Clinical) Staffing
Business & Public Services/HR, Staffing & Recruitment Services/Professional & Technical Staffing (IT/Engineering/Healthcare/Finance)
SECONDARYHLAGAAAI
Patient Recruitment, Site Feasibility & Trial Enablement CROs

Keywords

  • Oncology clinical trials
  • Contract research organization
  • Clinical trial management
  • Drug development consulting
  • Biotech clinical services

Where Highline Sciences is headquartered

Location

Headquarters

HQ city
San Francisco
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Highline Sciences business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

  1. Full-Service Clinical Trial Support: Comprehensive CRO services including project management, clinical monitoring, data management, biostatistics, regulatory affairs, and medical writing for Phase I-III oncology trials
  2. Functional Service Support: Individual resource augmentation and specialized services such as site management, feasibility, study startup, investigator payments, and quality assurance
  3. Clinical Development Consulting: Consulting services for early-stage companies preparing for clinical development and established companies needing program support
  4. Staff Augmentation: Providing qualified clinical staff at all levels to augment client workforces, including evaluation of existing staff and identification of specialists

Go-to-market motion1 record

Distribution channels2 records

Marketing channels3 records

Highline Sciences product offering

Product offering

Core offering

Highline Sciences is a specialized, full-service Contract Research Organization (CRO) and consultancy that provides oncology-focused clinical trial support for small to mid-market biotech companies. Services span Phase I through Phase III trials and include project management, clinical monitoring, data management, biostatistics, regulatory affairs, safety/pharmacovigilance, medical writing, and quality assurance, delivered as full-service, functional, or staff augmentation engagements.

Product overview

Highline Sciences is a specialized, full-service CRO and consultancy founded from within an oncology biotech. It offers a comprehensive suite of clinical trial services structured as integrated modules including project management, feasibility and site identification, study startup, clinical monitoring and site management, regulatory services, data management, biostatistics, medical affairs, safety and pharmacovigilance, medical writing, and quality assurance. The company also provides staff augmentation, clinical development consulting, and specialized oncology trial design services (Phases I-III, orphan designation, first-in-human, modern basket/umbrella designs, biomarker and companion diagnostics, dose escalation). Services are delivered using operational technology platforms including Veeva Vault CTMS/eTMF, Oracle Argus Safety, and EDC systems (Medidata RAVE, Medrio). Highline Sciences was acquired by Tempus and has been rebranded as Tempus Compass, integrating into Tempus's broader data and AI-powered healthcare solutions.

Differentiator

Problem solved

Functional benefit

Brands

  • Tempus Compass: The rebranded clinical trial solutions division of Highline Sciences under Tempus, offering clinical trial services to biopharma companies.

Products and services

  • Clinical Trial Services Full-service and functional clinical trial support for small to mid-market biotech companies, spanning Phase I through Phase III, with deep expertise in oncology. Delivered as a coordinated engagement with A-team support globally.
  • Clinical Development Consulting Consulting services for early-stage biotech companies preparing for clinical development and for established companies needing extra program support, including trial planning, forecasting, and execution.
  • Staff Augmentation Workforce augmentation service that evaluates existing client staff, identifies required additional skills, and supplies qualified clinical professionals and industry specialists at all levels to complement sponsor workforces.

Companies that use Highline Sciences

Customer profile

Segments3 records

Ideal customer profiles2 records

Highline Sciences technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration4 records

Feature3 records

Highline Sciences partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and flagship.

  • VeevacoreTechnology or IntegrationHighline Sciences utilizes Veeva Vault CTMS (Clinical Trial Management System) and eTMF (electronic Trial Master File) systems for integrated study management. The integration enables streamlined processes from site activation through close-out within a single system, increasing visibility, quality, and efficiency throughout the study lifecycle.
  • OraclecoreTechnology or IntegrationHighline Sciences uses Oracle Argus Safety, the industry-leading adverse event management system. The Argus Safety database can be configured for single or multiple studies and compounds within a sponsor-specific Argus Enterprise, with all configuration completed in-house for flexibility and responsiveness.
  • MedidatacoreTechnology or IntegrationMedidata RAVE is a preferred EDC system due to its flexibility in design and ease of use for site staff. Data is readily visible and available for reporting, improving ability to analyze and make key decisions throughout clinical trials.
  • TempusflagshipStrategic or Co-development PartnerHighline Sciences has been acquired by Tempus and operates under the Tempus Compass brand. Tempus brings the power of data and AI to healthcare and offers multiple solutions for biopharma ranging from sequencing and data collaborations to clinical trial solutions. This acquisition integrates Highline's CRO services with Tempus's broader data and AI capabilities.

Recent moves6 records

Expansion highlights4 records

Highline Sciences competitors and assessment

Company assessment

Broad incumbents

  • Tempus AI: Parent company of Highline Sciences (now Tempus Compass). Tempus is a data and AI healthcare company that acquired Highline to offer clinical trial solutions alongside its sequencing and data collaboration services. Relevant as the integrated platform that Highline now operates within.
  • IQVIA: Global tier-1 CRO offering full-service clinical trial support across all therapeutic areas including oncology. Competitor to Highline for mid-market and large biopharma oncology trials, with broader scale, site networks, and technology platform.
  • ICON plc: Global CRO providing full-service and functional clinical trial services across therapeutic areas including oncology. Competes with Highline/Tempus Compass for biotech-sponsored oncology trials, particularly at the larger end of the market.
  • Parexel International: Large global CRO offering comprehensive oncology clinical development services. A direct competitor in the mid-market oncology CRO space where Highline/Tempus Compass operates, with stronger late-phase capabilities.
  • Fortrea (formerly LabCorp Drug Development): Global full-service CRO spun out from LabCorp, offering clinical development services across therapeutic areas including oncology. Competes broadly with Highline for oncology trial work at scale.
  • Syneos Health (now part of Elliott/Private): Global CRO with full-service and functional service offerings across therapeutic areas including oncology. Competes with Highline/Tempus Compass for mid-market and enterprise biotech sponsors.

Direct peers

  • Medpace Holdings: Mid-sized full-service CRO with particular strength in oncology, cardiovascular, and metabolic therapeutic areas. Medpace serves small and mid-market biotech sponsors with a full-service model, directly competing with Highline/Tempus Compass in oncology Phase I-III trials.
  • Worldwide Clinical Trials: Mid-sized CRO with strong oncology and early-phase specialization serving small and mid-market biopharma. Comparable to Highline in its boutique positioning and therapeutic-area focus, making it a direct peer for oncology biotech clients.
  • Novella Clinical (IQVIA Oncology): Oncology-focused CRO unit within IQVIA historically serving small/mid-market oncology biotechs. Direct historical competitor to Highline Sciences in specialized oncology trial services for emerging biotech sponsors.

Emerging players

  • Precision Medicine Group: Specialized clinical development services provider with oncology focus and complementary biomarker/precision medicine capabilities. Overlaps with Highline's oncology specialty positioning and biomarker-driven trial design expertise.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

Highline Sciences social profiles

Digital presence

Highline Sciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Highline Sciences leadership team

Management profile

Number of profiles

Profiles1 record

Highline Sciences funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Highline Sciences M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Highline Sciences

What does Highline Sciences do?

Highline Sciences is a specialized, full-service Contract Research Organization (CRO) and consultancy that provides oncology-focused clinical trial support for small to mid-market biotech companies. Services span Phase I through Phase III trials and include project management, clinical monitoring, data management, biostatistics, regulatory affairs, safety/pharmacovigilance, medical writing, and quality assurance, delivered as full-service, functional, or staff augmentation engagements.

Is Highline Sciences a public or private company?

Highline Sciences is a private company. It is classified as corporate owned and is currently acquired.

When was Highline Sciences founded?

Highline Sciences was founded in 2014. It employs 1 to 10 people.

Where is Highline Sciences based?

Highline Sciences is headquartered in San Francisco, United States, in the North America region.

How does Highline Sciences make money?

Four revenue lines are on record. Full-Service Clinical Trial Support is the primary driver. The others are functional Service Support, clinical Development Consulting and staff Augmentation.

Who are Highline Sciences's main competitors?

Broad incumbents on record are Tempus AI, IQVIA, ICON plc, Parexel International, Fortrea (formerly LabCorp Drug Development) and Syneos Health (now part of Elliott/Private). Direct peers are Medpace Holdings, Worldwide Clinical Trials and Novella Clinical (IQVIA Oncology). Precision Medicine Group is listed as an emerging player.

Does Highline Sciences have an API?

No public API is recorded for Highline Sciences.

What industry is Highline Sciences in?

Highline Sciences's product category is Clinical Research Organization (CRO) Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease). Its NAICS code is 54171 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals